Free Trial

BioLargo (BLGO) Competitors

BioLargo logo
$0.19 -0.01 (-2.76%)
As of 07/16/2025 03:06 PM Eastern

BLGO vs. AMTX, VGAS, LODE, ZTEK, TSE, ALTO, ORGN, LNZA, FSI, and LOOP

Should you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Aemetis (AMTX), Verde Clean Fuels (VGAS), Comstock (LODE), Zentek (ZTEK), Trinseo (TSE), Alto Ingredients (ALTO), Origin Materials (ORGN), LanzaTech Global (LNZA), Flexible Solutions International (FSI), and Loop Industries (LOOP). These companies are all part of the "chemicals" industry.

BioLargo vs. Its Competitors

Aemetis (NASDAQ:AMTX) and BioLargo (NASDAQ:BLGO) are both small-cap chemicals companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

BioLargo has lower revenue, but higher earnings than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aemetis$267.64M0.57-$87.54M-$1.87-1.47
BioLargo$12.23M4.86-$3.50M-$0.01-19.40

In the previous week, Aemetis had 2 more articles in the media than BioLargo. MarketBeat recorded 2 mentions for Aemetis and 0 mentions for BioLargo. BioLargo's average media sentiment score of 1.16 beat Aemetis' score of 0.93 indicating that BioLargo is being referred to more favorably in the news media.

Company Overall Sentiment
Aemetis Positive
BioLargo Positive

Aemetis has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Comparatively, BioLargo has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500.

Aemetis currently has a consensus price target of $13.63, suggesting a potential upside of 395.45%. Given Aemetis' stronger consensus rating and higher probable upside, research analysts plainly believe Aemetis is more favorable than BioLargo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aemetis
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

27.0% of Aemetis shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 14.7% of Aemetis shares are held by company insiders. Comparatively, 20.3% of BioLargo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -36.92%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
Aemetis-36.92% N/A -35.80%
BioLargo -11.45%-39.90%-22.06%

Summary

Aemetis beats BioLargo on 9 of the 16 factors compared between the two stocks.

Get BioLargo News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLGO vs. The Competition

MetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ Exchange
Market Cap$59.39M$11.86B$9.26B$9.31B
Dividend YieldN/A1.09%2.06%4.09%
P/E Ratio-19.40N/A16.0619.69
Price / Sales4.863.51115.71100.25
Price / CashN/A14.8014.6157.53
Price / Book19.4011.144.475.67
Net Income-$3.50M$989.69M$622.34M$257.51M
7 Day Performance-3.00%-1.50%-3.17%-0.16%
1 Month Performance-5.13%-2.57%3.32%9.89%
1 Year Performance-25.76%-12.88%94.42%15.08%

BioLargo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLGO
BioLargo
0.8269 of 5 stars
$0.19
-2.8%
N/A-26.9%$59.39M$12.23M-19.4030Positive News
AMTX
Aemetis
2.7317 of 5 stars
$3.49
+5.4%
$13.63
+290.4%
-30.4%$193.24M$267.64M-1.87160News Coverage
Positive News
VGAS
Verde Clean Fuels
0.2263 of 5 stars
$3.43
+0.3%
N/A-26.3%$152.81MN/A-7.152News Coverage
LODE
Comstock
0.9191 of 5 stars
$3.70
-1.9%
$26.00
+602.7%
+110.7%$119.94M$3.38M-30.8330
ZTEK
Zentek
0.5079 of 5 stars
$1.11
flat
N/A-8.5%$116.23M$1.22M-18.5024
TSE
Trinseo
1.0238 of 5 stars
$2.96
+2.1%
N/A-2.6%$105.52M$3.51B-0.302,950
ALTO
Alto Ingredients
3.365 of 5 stars
$1.24
+0.8%
$5.50
+343.5%
-30.8%$95.00M$965.26M-1.51420News Coverage
ORGN
Origin Materials
2.1525 of 5 stars
$0.61
+7.6%
$1.50
+147.8%
-45.1%$90.77M$31.28M-0.90160Positive News
Gap Down
LNZA
LanzaTech Global
2.5512 of 5 stars
$0.31
+12.6%
$2.00
+548.5%
-86.0%$71.54M$49.59M-0.463News Coverage
FSI
Flexible Solutions International
3.6789 of 5 stars
$5.62
-6.3%
N/A+196.9%$71.08M$36.48M17.0340News Coverage
LOOP
Loop Industries
1.5004 of 5 stars
$1.23
+2.5%
N/A-38.5%$58.69M$10.89M-3.8490Earnings Report
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:BLGO) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners